Data / Form D filings / JeNu Biosciences Inc
JeNu Biosciences Inc: Form D filings
JeNu Biosciences Inc, a health care company in Seattle, WA, filed 5 Form D notices with the SEC between 2010 and 2014. The latest, on April 8, 2014, reports $1.1 million sold of a $1.2 million offering to 3 investors.
Find out what JeNu Biosciences Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1101 N. NORTHLAKE WAY, SUITE 200, Seattle, WA, 98103
- Phone
- (866) 565-5368
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1507477
The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 8, 2014 | New notice | $1,200,000 | $1,148,097 | $51,903 | 3 | Mar 31, 2014 | sec.gov |
| Apr 20, 2012 | Amendment | $3,350,000 | $3,350,000 | $0 | 7 | Dec 27, 2011 | sec.gov |
| Jan 10, 2012 | New notice | $3,000,000 | $1,550,000 | $1,450,000 | 2 | Dec 27, 2011 | sec.gov |
| Sep 1, 2011 | Amendment | $500,000 | $500,000 | $0 | 7 | Aug 26, 2011 | sec.gov |
| Dec 13, 2010 | New notice | $250,000 | $250,000 | $0 | 2 | Dec 7, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Colette Courtion | Executive Officer | |
| Pete Higgins | Director | |
| Cindy Crawford | Director | |
| Michael Slade | Director |
Other health care companies in Washington that filed recently
- Seattle Neurosound Solutions, Inc. $100,000 · Sep 22, 2026
- DexCare, Inc. $12.9 million · Sep 14, 2026
Every Form D from the week of Apr 7, 2014 · All recent filings in Washington · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what JeNu Biosciences Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.